期刊
TRANSLATIONAL NEURODEGENERATION
卷 10, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s40035-021-00230-9
关键词
Alzheimer's disease; Mild cognitive impairment; Optical coherence tomography; Optical coherence tomography angiography; Retina; Biomarkers; In vivo imaging
Retinal changes can reflect brain pathology and serve as potential biomarkers for early diagnosis of Alzheimer's disease. Studies have shown that neurodegeneration and microvascular changes exist in AD, MCI, and even preclinical AD.
As the most common form of dementia, Alzheimer's disease (AD) is characterized by progressive cognitive impairments and constitutes a major social burden. Currently, the invasiveness and high costs of tests have limited the early detection and intervention of the disease. As a unique window of the brain, retinal changes can reflect the pathology of the brain. In this review, we summarize current understanding of retinal structures in AD, mild cognitive impairment (MCI) and preclinical AD, focusing on neurodegeneration and microvascular changes measured using optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) technologies. The literature suggests that the impairment of retinal microvascular network and neural microstructure exists in AD, MCI and even preclinical AD. These findings provide valuable insights into a better understanding of disease pathogenesis and demonstrate that retinal changes are potential biomarkers for early diagnosis of AD and monitoring of disease progression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据